ASP2998

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP2998, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors [Phase 1, Phase 2]

See pricing